These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24038301)

  • 1. The structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression.
    Quilty LC; Robinson JJ; Rolland JP; Fruyt FD; Rouillon F; Bagby RM
    Int J Methods Psychiatr Res; 2013 Sep; 22(3):175-84. PubMed ID: 24038301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice.
    Bondolfi G; Jermann F; Rouget BW; Gex-Fabry M; McQuillan A; Dupont-Willemin A; Aubry JM; Nguyen C
    J Affect Disord; 2010 Mar; 121(3):268-72. PubMed ID: 19660815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent classes of nonresponders, rapid responders, and gradual responders in depressed outpatients receiving antidepressant medication and psychotherapy.
    Thibodeau MA; Quilty LC; De Fruyt F; De Bolle M; Rouillon F; Bagby RM
    Depress Anxiety; 2015 Mar; 32(3):213-20. PubMed ID: 25069431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial.
    Driessen E; Van HL; Schoevers RA; Cuijpers P; van Aalst G; Don FJ; Hendriksen M; Kool S; Molenaar PJ; Peen J; Dekker JJ
    BMC Psychiatry; 2007 Oct; 7():58. PubMed ID: 17963493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the Affective Self Rating Scale for manic, depressive, and mixed affective states.
    Adler M; Liberg B; Andersson S; Isacsson G; Hetta J
    Nord J Psychiatry; 2008; 62(2):130-5. PubMed ID: 18569776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression.
    Carter JD; Frampton CM; Mulder RT; Luty SE; Joyce PR
    J Affect Disord; 2010 Jul; 124(1-2):202-6. PubMed ID: 20004477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative validation of proxy-based Montgomery-Åsberg depression rating scale and cornell scale for depression in dementia in nursing home residents with dementia.
    Leontjevas R; Gerritsen DL; Vernooij-Dassen MJ; Smalbrugge M; Koopmans RT
    Am J Geriatr Psychiatry; 2012 Nov; 20(11):985-93. PubMed ID: 21989316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
    Davey CG; Chanen AM; Cotton SM; Hetrick SE; Kerr MJ; Berk M; Dean OM; Yuen K; Phelan M; Ratheesh A; Schäfer MR; Amminger GP; Parker AG; Piskulic D; Harrigan S; Mackinnon AJ; Harrison BJ; McGorry PD
    Trials; 2014 Nov; 15():425. PubMed ID: 25370185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability.
    Gonzalez JM; Bowden CL; Katz MM; Thompson P; Singh V; Prihoda TJ; Dahl M
    Int J Methods Psychiatr Res; 2008; 17(4):198-209. PubMed ID: 18792087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining remission on the Montgomery-Asberg depression rating scale.
    Zimmerman M; Posternak MA; Chelminski I
    J Clin Psychiatry; 2004 Feb; 65(2):163-8. PubMed ID: 15003068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
    Zimmerman M; Posternak MA; Chelminski I
    J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients.
    Seemüller F; Schennach R; Musil R; Obermeier M; Adli M; Bauer M; Brieger P; Laux G; Gaebel W; Falkai P; Riedel M; Möller HJ
    BMC Psychiatry; 2023 Jul; 23(1):548. PubMed ID: 37507656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression.
    Levitan RD; Levitt AJ; Michalak EE; Morehouse R; Ramasubbu R; Yatham LN; Tam EM; Lam RW
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30063303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adolescents with depression: the effect of transference interventions in a randomized controlled study of dynamic psychotherapy.
    Ulberg R; Hersoug AG; Høglend P
    Trials; 2012 Sep; 13():159. PubMed ID: 22950546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and monitoring of symptom severity and change in depressed outpatients.
    Senra C
    J Clin Psychol; 1996 May; 52(3):317-24. PubMed ID: 8835694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice].
    Guelfi JD; Bouhassira M; Bonett-Perrin E; Lancrenon S
    Encephale; 1999; 25(3):265-70. PubMed ID: 10434153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
    Fantino B; Moore N
    BMC Psychiatry; 2009 May; 9():26. PubMed ID: 19473506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment factor structures of the Montgomery and Åsberg Depression Rating scale as predictors of response to escitalopram in Indian patients with non-psychotic major depressive disorder.
    Basu A; Chadda R; Sood M; Rizwan SA
    Asian J Psychiatr; 2017 Aug; 28():154-159. PubMed ID: 28784374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.